Alere Triage® 98100Recalls & reported problems
Alere San Diego, Inc. · Alere Triage® D-Dimer Test · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00893038002326), received between Oct 11, 2017 and Dec 13, 2018 — classified as 1 injury, 3 malfunctions.
The most frequently reported specific device problem is “Incorrect, Inadequate or Imprecise Result or Readings” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Incorrect, Inadequate or Imprecise Result or Readings3
- High Test Results1
Patient problems
- No Consequences Or Impact To Patient3
- No Code Available1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 13, 2018Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
CUSTOMER REPORTED A DISCORDANT D-DIMER RESULT WITH 1 PATIENT SAMPLE WHILE RUNNING A WHOLE BLOOD TO PLASMA CORRELATION STUDY. TRIAGE D-DIMER: WHOLE BLOOD: 215NG/ML; PLASMA: 448NG/ML. PATIENT SAMPLE RESULTED ON STAGO WITH A D-DIMER OF 0.62MG/ML FEU. CUSTOMER STATED STAGO RESULTS WOULD HAVE BEEN WHAT WAS USED BY THE PHYSICIAN. FACILITY TRIAGE D-DIMER CUT-OFF = 400NG/ML, FACILITY STAGO D-DIMER CUT-OFF = 0.50MG/ML FEU. CUSTOMER COULD NOT PROVIDE DIAGNOSIS INFORMATION FOR THE PATIENT BUT STATED THE PATIENT "PRESENTED WITH DIZZINESS, NAUSEA AND PLEURISY, ANXIETY AND DEPRESSION".
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8162942 ↗MalfunctionSep 6, 2018Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
THE CUSTOMER REPORTED VARIABILITY BETWEEN RESULTS PRODUCED ON THE TRIAGE D-DIMER SYSTEM. ON (B)(6) 2018 A PATIENT PRESENTED TO THE CUSTOMER SITE WITH LOCALIZED EDEMA. PATIENT SAMPLE WAS TESTED ON TRIAGE PLATFORM AND PRODUCED D-DIMER RESULTS OF 455NG/ML, 205NG/ML, 233NG/ML, 307NG/ML AND 445NG/ML. THE SPECIFIC TIME OF TESTING WAS NOT PROVIDED BUT CUSTOMER STATED TESTING WAS ALL DONE ON THE SAME DAY WITH THE SAME DRAW. CUSTOMER INDICATED THE RESULT OF 455NG/ML WAS THE REPORTED RESULT FOR THE PATIENT. CLINICS REFERENCE RANGE FOR TRIAGE D-DIMER IS <400NG/ML. CUSTOMER STATED NO OTHER LAB TESTS WERE PERFORMED AND CUSTOMER DID NOT KNOW PATIENT DIAGNOSIS/OUTCOME, TREATMENT OR MEDICAL HISTORY.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7853079 ↗MalfunctionSep 6, 2018Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
THE CUSTOMER REPORTED VARIABILITY BETWEEN RESULTS PRODUCED ON THE TRIAGE D-DIMER SYSTEM. CUSTOMER STATED ON (B)(6) 2018 A PATIENT PRESENTED TO THE CLINIC WITH "PAIN IN LOWER LEFT EXTREMITY (CLOT)". PATIENT SAMPLE WAS TESTED ON TRIAGE AND PRODUCED D-DIMER RESULTS OF 202NG/ML, 163NG/ML, AND 571NG/ML. THE SPECIFIC TIME OF TESTING WAS NOT PROVIDED BUT CUSTOMER STATED TESTING WAS ALL DONE ON THE SAME DAY. CLINICS REFERENCE RANGE FOR TRIAGE D-DIMER IS <400NG/ML. CUSTOMER STATED NO OTHER LAB TESTS WERE PERFORMED AND CUSTOMER DID NOT KNOW PATIENT DIAGNOSIS/OUTCOME, TREATMENT OR MEDICAL HISTORY.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7853057 ↗InjuryOct 11, 2017High Test Results; High Test Results
ON (B)(6) 2017, THE PATIENT ARRIVED AT THE PHYSICIAN'S OFFICE COMPLAINING OF CHEST PAIN. BOTH D-DIMER AND TNI TESTING WAS CONDUCTED ON THE PATIENT. A WHOLE-BLOOD EDTA SAMPLE WAS COLLECTED AT 4:30 PM AND THE TRIAGE D-DIMER PANEL PRODUCED AN ABNORMAL D-DIMER RESULT OF 1030 NG/ML D-DU. THE TNI RESULTS ARE NOT AVAILABLE PER CUSTOMER BUT PRODUCED A NORMAL RESULT. BASED ON THE ABNORMAL D-DIMER RESULT, THE PATIENT WAS SENT TO THE EMERGENCY ROOM FOR A CHEST CT. THE CHEST CT SHOWED NO EVIDENCE OF PULMONARY EMBOLISM AND NO EVIDENCE OF ACUTE CARDIO PULMONARY DISEASE. AT THE EMERGENCY ROOM, CONFIRMATORY TESTING WAS CONDUCTED USING THE HEMOSIL SYSTEM AND RESULTED IN A NORMAL D-DIMER VALUE OF 300 NG/ML D-DU. ON (B)(6) 2017, THE SAME WHOLE-BLOOD EDTA SAMPLE WAS TESTED AN ADDITIONAL TWO TIMES AT APPROXIMATELY 1:00 PM. THE TRIAGE D-DIMER PANEL PRODUCED ABNORMAL RESULTS OF 968 NG/ML D-DU AND 825 NG/ML D-DU. THE FACILITY'S NORMAL D-DIMER CUTOFF FOR BOTH THE TRIAGE AND HEMOSIL SYSTEMS WAS REPORTED TO BE 400 NG/ML D-DU.
Patient problems: No Code Available
MAUDE report 6942683 ↗
Other Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control devices
- STA® - Liatest® D-Di 00515Diagnostica Stago · FIBRINOGEN AND FIBRIN SPLIT PRODUCTS, ANTIGEN, ANTISERUM, CONTROL2 recalls0 reports
- VIDAS® D-Dimer Exclusion II ™ 30455-01Biomerieux SA · Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control1 recall2 reports
- INNOVANCE® D-Dimer 10445981Siemens Healthcare Diagnostics Products GmbH · FIBRINOGEN AND FIBRIN SPLIT PRODUCTS, ANTIGEN, ANTISERUM, CONTROL9 reports
- INNOVANCE® D-Dimer 10445982Siemens Healthcare Diagnostics Products GmbH · FIBRINOGEN AND FIBRIN SPLIT PRODUCTS, ANTIGEN, ANTISERUM, CONTROL8 reports
- INNOVANCE® D-Dimer Controls 10446006Siemens Healthcare Diagnostics Products GmbH · FIBRINOGEN AND FIBRIN SPLIT PRODUCTS, ANTIGEN, ANTISERUM, CONTROL2 reports
- Triage 98100Quidel Cardiovascular Inc. · FIBRINOGEN AND FIBRIN SPLIT PRODUCTS, ANTIGEN, ANTISERUM, CONTROL1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page